Home » Topics » Regulatory » Patents

Patents
RSS

Allelix describes D4 antagonists for schizophrenia

Aug. 16, 1996

5-HT2 receptor ligands reported by Allelix

Aug. 16, 1996

Hypolipidemic agents described by Bayer

Aug. 16, 1996

RPR reports squalene synthase inhibitors

Aug. 16, 1996

Takeda claims benzothiepin derivatives to treat bone disease

Aug. 16, 1996

Cannabinoid receptor ligands for glaucoma reported by Merck Frosst

Aug. 16, 1996

Kyorin, Sagami report antineoplastic acrylamides

Aug. 16, 1996

Pola claims antisense oligonucleotides for cancer

Aug. 16, 1996

Mitsui Toatsu claims potential antitumor agents

Aug. 16, 1996

MAM-102: antineoplastic protein tyrosine kinase inhibitor

Aug. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 12, 2025.
Could restricting diversity efforts stall women’s health research?
BioWorld
Recent progress in redressing the historical underfunding and neglect of women’s health could be undermined by the backlash against diversity, equity and...
Alkermes’ alixorexton hits endpoints in narcolepsy phase II
BioWorld
Alkermes plc’s placebo-controlled phase II study of alixorexton in treating narcolepsy type 2 (NT2) hit its dual primary endpoints, producing statistically...
Pazdur ‘optimal fit’ to lead FDA’s CDER
BioWorld
In reaching within to name 26-year FDA veteran Richard Pazdur as the next CDER director, FDA Commissioner Marty Makary likely chose the best possible person to...